Feedback / Questions
177Lu-rosopatamab tetraxetan (TLX591) - Telix
https://www.globenewswire.com/news-release/2026/03/09/3252392/0/en/ProstACT-Global-Phase-3-Study-Part-1-Achieves-Primary-Objectives.html
Mar 9, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next